首页 > 最新文献

Mmwr Surveillance Summaries最新文献

英文 中文
Intimate Partner Violence-Related Homicides of Hispanic and Latino Persons - National Violent Death Reporting System, United States, 2003-2021.
IF 37.3 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-12 DOI: 10.15585/mmwr.ss7309a1
Sarah Treves-Kagan, Yanet Ruvalcaba, Daniel T Corry, Colleen M Ray, Vi D Le, Rosalyn D Lee, Carlos Siordia, Melissa C Mercado, Lianne Fuino Estefan, Tatiana M Vera, Megan C Kearns, Laura M Mercer Kollar, Delight E Satter, Ana Penman-Aguilar, José T Montero
<p><strong>Problem/condition: </strong>In 2022, homicide was the second leading cause of death for Hispanic and Latino persons aged 15-24 years in the United States, the third leading cause of death for those aged 25-34 years, and the fourth leading cause of death for those aged 1-14 years. The majority of homicides of females, including among Hispanic and Latino persons, occur in the context of intimate partner violence (IPV). This report summarizes data from CDC's National Violent Death Reporting System (NVDRS) on IPV-related homicides of Hispanic and Latino persons in the United States.</p><p><strong>Period covered: </strong>2003-2021.</p><p><strong>Description of system: </strong>NVDRS collects data regarding violent deaths in the United States and links three sources: death certificates, coroner or medical examiner reports, and law enforcement reports. IPV-related homicides include both intimate partner homicides (IPHs) by current or former partners and homicides of corollary victims (e.g., children, family members, and new partners). Findings describe victim and suspect sex, age group, and race and ethnicity; method of injury; type of location where the homicide occurred; precipitating circumstances (i.e., events that contributed to the homicide); and other selected characteristics. Deaths related to each other (e.g., an ex-partner kills the former partner and their new partner) are linked into a single incident. State participation in NVDRS has expanded over time, and the number of states participating has varied by year; data from all available years (2003-2021) and U.S. jurisdictions (49 states, Puerto Rico, and the District of Columbia) were used for this report. Of the 49 states that collect data, all except California and Texas collect data statewide; Puerto Rico and District of Columbia data are jurisdiction wide. Florida was excluded because the data did not meet the completeness threshold for circumstances.</p><p><strong>Results: </strong>NVDRS collected data on 24,581 homicides of Hispanic and Latino persons, and data from all available years (2003-2021) and U.S. jurisdictions (49 states, Puerto Rico, and the District of Columbia) were examined. Among homicides with known circumstances (n = 17,737), a total of 2,444 were classified as IPV-related (13.8%). Nearly half of female homicides (n = 1,453; 48.2%) and 6.7% (n = 991) of male homicides were IPV-related; however, among all Hispanic and Latino homicides, most victims were male (n = 20,627; 83.9%). Among the 2,319 IPV-related homicides with known suspects, 85% (n = 1,205) of suspects were current or former partners for female victims, compared with 26.2% (n = 236) for male Hispanic and Latino victims. Approximately one fifth (71 of 359 [19.8%]) of female IPV-related homicide victims of childbearing age with known pregnancy status were pregnant or ≤1 year postpartum. Approximately 5% of IPV-related homicide victims were identified as Black Hispanic or Latino persons (males: n =
{"title":"Intimate Partner Violence-Related Homicides of Hispanic and Latino Persons - National Violent Death Reporting System, United States, 2003-2021.","authors":"Sarah Treves-Kagan, Yanet Ruvalcaba, Daniel T Corry, Colleen M Ray, Vi D Le, Rosalyn D Lee, Carlos Siordia, Melissa C Mercado, Lianne Fuino Estefan, Tatiana M Vera, Megan C Kearns, Laura M Mercer Kollar, Delight E Satter, Ana Penman-Aguilar, José T Montero","doi":"10.15585/mmwr.ss7309a1","DOIUrl":"10.15585/mmwr.ss7309a1","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Problem/condition: &lt;/strong&gt;In 2022, homicide was the second leading cause of death for Hispanic and Latino persons aged 15-24 years in the United States, the third leading cause of death for those aged 25-34 years, and the fourth leading cause of death for those aged 1-14 years. The majority of homicides of females, including among Hispanic and Latino persons, occur in the context of intimate partner violence (IPV). This report summarizes data from CDC's National Violent Death Reporting System (NVDRS) on IPV-related homicides of Hispanic and Latino persons in the United States.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Period covered: &lt;/strong&gt;2003-2021.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Description of system: &lt;/strong&gt;NVDRS collects data regarding violent deaths in the United States and links three sources: death certificates, coroner or medical examiner reports, and law enforcement reports. IPV-related homicides include both intimate partner homicides (IPHs) by current or former partners and homicides of corollary victims (e.g., children, family members, and new partners). Findings describe victim and suspect sex, age group, and race and ethnicity; method of injury; type of location where the homicide occurred; precipitating circumstances (i.e., events that contributed to the homicide); and other selected characteristics. Deaths related to each other (e.g., an ex-partner kills the former partner and their new partner) are linked into a single incident. State participation in NVDRS has expanded over time, and the number of states participating has varied by year; data from all available years (2003-2021) and U.S. jurisdictions (49 states, Puerto Rico, and the District of Columbia) were used for this report. Of the 49 states that collect data, all except California and Texas collect data statewide; Puerto Rico and District of Columbia data are jurisdiction wide. Florida was excluded because the data did not meet the completeness threshold for circumstances.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;NVDRS collected data on 24,581 homicides of Hispanic and Latino persons, and data from all available years (2003-2021) and U.S. jurisdictions (49 states, Puerto Rico, and the District of Columbia) were examined. Among homicides with known circumstances (n = 17,737), a total of 2,444 were classified as IPV-related (13.8%). Nearly half of female homicides (n = 1,453; 48.2%) and 6.7% (n = 991) of male homicides were IPV-related; however, among all Hispanic and Latino homicides, most victims were male (n = 20,627; 83.9%). Among the 2,319 IPV-related homicides with known suspects, 85% (n = 1,205) of suspects were current or former partners for female victims, compared with 26.2% (n = 236) for male Hispanic and Latino victims. Approximately one fifth (71 of 359 [19.8%]) of female IPV-related homicide victims of childbearing age with known pregnancy status were pregnant or ≤1 year postpartum. Approximately 5% of IPV-related homicide victims were identified as Black Hispanic or Latino persons (males: n = ","PeriodicalId":48549,"journal":{"name":"Mmwr Surveillance Summaries","volume":"73 9","pages":"1-17"},"PeriodicalIF":37.3,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655122/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Waterborne Disease Outbreaks Associated with Splash Pads - United States, 1997-2022.
IF 37.3 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-05 DOI: 10.15585/mmwr.ss7308a1
Hannah Lawinger, Amina Khan, Colleen Lysen, Marydale Oppert, Vince R Hill, Jonathan S Yoder, Virginia A Roberts, Mia C Mattioli, Michele C Hlavsa

Problem/condition: Splash pads are recreational interactive water venues that spray or jet water on users. Splash pads are intended for children aged <5 years and designed so that water typically does not collect in areas accessible to users, thereby minimizing the risk for drowning. Splash pads were first found to be associated with waterborne disease outbreaks in 1997.

Period covered: 1997-2022.

Description of system: Since 1971, waterborne disease outbreaks have been voluntarily reported to CDC by state, local, and territorial health departments using a standard paper form via the Waterborne Disease and Outbreak Surveillance System (WBDOSS). Beginning in 2009, WBDOSS reporting was made available exclusively through the National Outbreak Reporting System, a web-based platform. This report characterizes waterborne disease outbreaks associated with splash pads reported to CDC that occurred during 1997-2022.

Results: During 1997-2022, public health officials from 23 states and Puerto Rico reported 60 waterborne disease outbreaks associated with splash pads. These reported outbreaks resulted in 10,611 cases, 152 hospitalizations, 99 emergency department visits, and no reported deaths. The 40 (67%) outbreaks confirmed to be caused, in part, by Cryptosporidium resulted in 9,622 (91%) cases and 123 (81%) hospitalizations. Two outbreaks suspected to be caused by norovirus resulted in 72 (73%) emergency department visits.

Interpretation: Waterborne pathogens that cause acute gastrointestinal illness can be transmitted by ingesting water contaminated with feces from infected persons. Chlorine is the primary barrier to pathogen transmission in splash pad water. However, Cryptosporidium is tolerant to chlorine and is the most common cause of reported waterborne disease outbreaks associated with splash pads.

Public health action: Public health officials and the aquatics sector can use the findings in this report to promote the prevention of splash pad-associated outbreaks (e.g., recommended user behaviors) and guide the construction, operation, and management of splash pads. Public health practitioners and the aquatics sector also can collaborate to voluntarily adopt CDC's Model Aquatic Health Code recommendations to prevent waterborne illness associated with splash pads.

{"title":"Waterborne Disease Outbreaks Associated with Splash Pads - United States, 1997-2022.","authors":"Hannah Lawinger, Amina Khan, Colleen Lysen, Marydale Oppert, Vince R Hill, Jonathan S Yoder, Virginia A Roberts, Mia C Mattioli, Michele C Hlavsa","doi":"10.15585/mmwr.ss7308a1","DOIUrl":"10.15585/mmwr.ss7308a1","url":null,"abstract":"<p><strong>Problem/condition: </strong>Splash pads are recreational interactive water venues that spray or jet water on users. Splash pads are intended for children aged <5 years and designed so that water typically does not collect in areas accessible to users, thereby minimizing the risk for drowning. Splash pads were first found to be associated with waterborne disease outbreaks in 1997.</p><p><strong>Period covered: </strong>1997-2022.</p><p><strong>Description of system: </strong>Since 1971, waterborne disease outbreaks have been voluntarily reported to CDC by state, local, and territorial health departments using a standard paper form via the Waterborne Disease and Outbreak Surveillance System (WBDOSS). Beginning in 2009, WBDOSS reporting was made available exclusively through the National Outbreak Reporting System, a web-based platform. This report characterizes waterborne disease outbreaks associated with splash pads reported to CDC that occurred during 1997-2022.</p><p><strong>Results: </strong>During 1997-2022, public health officials from 23 states and Puerto Rico reported 60 waterborne disease outbreaks associated with splash pads. These reported outbreaks resulted in 10,611 cases, 152 hospitalizations, 99 emergency department visits, and no reported deaths. The 40 (67%) outbreaks confirmed to be caused, in part, by Cryptosporidium resulted in 9,622 (91%) cases and 123 (81%) hospitalizations. Two outbreaks suspected to be caused by norovirus resulted in 72 (73%) emergency department visits.</p><p><strong>Interpretation: </strong>Waterborne pathogens that cause acute gastrointestinal illness can be transmitted by ingesting water contaminated with feces from infected persons. Chlorine is the primary barrier to pathogen transmission in splash pad water. However, Cryptosporidium is tolerant to chlorine and is the most common cause of reported waterborne disease outbreaks associated with splash pads.</p><p><strong>Public health action: </strong>Public health officials and the aquatics sector can use the findings in this report to promote the prevention of splash pad-associated outbreaks (e.g., recommended user behaviors) and guide the construction, operation, and management of splash pads. Public health practitioners and the aquatics sector also can collaborate to voluntarily adopt CDC's Model Aquatic Health Code recommendations to prevent waterborne illness associated with splash pads.</p>","PeriodicalId":48549,"journal":{"name":"Mmwr Surveillance Summaries","volume":"73 8","pages":"1-15"},"PeriodicalIF":37.3,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11616988/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abortion Surveillance - United States, 2022. 流产监控 - 美国,2022 年。
IF 37.3 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-11-28 DOI: 10.15585/mmwr.ss7307a1
Stephanie Ramer, Antoinette T Nguyen, Lisa M Hollier, Jessica Rodenhizer, Lee Warner, Maura K Whiteman
<p><strong>Problem/condition: </strong>CDC conducts abortion surveillance to document the number and characteristics of women obtaining legal induced abortions and the number of abortion-related deaths in the United States.</p><p><strong>Period covered: </strong>2022.</p><p><strong>Description of system: </strong>Each year, CDC requests abortion data from the central health agencies for the 50 states, the District of Columbia, and New York City. For 2022, a total of 48 reporting areas voluntarily provided aggregate abortion data to CDC. Of these, 47 reporting areas provided data each year during 2013-2022. Census and natality data were used to calculate abortion rates (number of abortions per 1,000 women aged 15-44 years) and ratios (number of abortions per 1,000 live births), respectively. Abortion-related deaths from 2021 were assessed as part of CDC's Pregnancy Mortality Surveillance System (PMSS).</p><p><strong>Results: </strong>For 2022, a total of 613,383 abortions were reported to CDC from 48 reporting areas. Among 47 reporting areas with data each year during 2013-2022, in 2022, a total of 609,360 abortions were reported, the abortion rate was 11.2 abortions per 1,000 women aged 15-44 years, and the abortion ratio was 199 abortions per 1,000 live births. From 2021 to 2022, the total number of abortions decreased 2% (from 622,108 total abortions), the abortion rate decreased 3% (from 11.6 abortions per 1,000 women aged 15-44 years), and the abortion ratio decreased 2% (from 204 abortions per 1,000 live births). From 2013 to 2022, the total number of reported abortions decreased 5% (from 640,154), the abortion rate decreased 10% (from 12.4 abortions per 1,000 women aged 15-44 years), and the abortion ratio increased 1% (from 198 abortions per 1,000 live births).In 2022, women in their 20s accounted for more than half of abortions (56.5%). Women aged 20-24 and 25-29 years accounted for the highest percentages of abortions (28.3% and 28.2%, respectively) and had the highest abortion rates (18.1 and 18.7 abortions per 1,000 women aged 20-24 and 25-29 years, respectively). By contrast, adolescents aged <15 years and women aged ≥40 years accounted for the lowest percentages of abortions (0.2% and 3.6%, respectively) and had the lowest abortion rates (0.4 and 2.5 abortions per 1,000 women aged <15 and ≥40 years, respectively). However, abortion ratios were highest among adolescents (aged ≤19 years) and lowest among women aged 30-39 years.From 2021 to 2022, abortion rates decreased among women aged ≥20 years and did not change among adolescents (aged ≤19 years). Abortion rates decreased from 2013 to 2022 among all age groups, except women aged 30-34 years for whom it increased. The decrease in the abortion rate from 2013 to 2022 was highest among adolescents compared with other age groups. From 2021 to 2022, abortion ratios increased for adolescents and decreased among women aged ≥20 years. From 2013 to 2022, abortion ratios increased among adoles
问题/条件:疾病预防控制中心对人工流产进行监测,以记录美国合法人工流产妇女的数量和特征,以及与人工流产相关的死亡人数:每年,美国疾病预防控制中心都会要求 50 个州、哥伦比亚特区和纽约市的中央卫生机构提供堕胎数据。2022 年,共有 48 个报告地区自愿向疾病预防控制中心提供堕胎综合数据。其中,47 个报告地区在 2013-2022 年期间每年都提供了数据。人口普查和出生率数据分别用于计算堕胎率(每千名 15-44 岁女性的堕胎数量)和比率(每千名活产婴儿的堕胎数量)。作为疾病预防控制中心妊娠死亡监测系统(PMSS)的一部分,对2021年与人工流产相关的死亡进行了评估:2022 年,48 个报告地区共向疾病预防控制中心报告了 613,383 例人工流产。在 2013-2022 年期间每年都有数据的 47 个报告地区中,2022 年共报告了 609360 例人工流产,人工流产率为每 1000 名 15-44 岁女性中有 11.2 例人工流产,人工流产率为每 1000 例活产中有 199 例人工流产。从 2021 年到 2022 年,堕胎总数下降了 2%(从 622 108 例堕胎总数下降),堕胎率下降了 3%(从每千名 15-44 岁妇女 11.6 例堕胎下降),堕胎率下降了 2%(从每千名活产婴儿 204 例堕胎下降)。从 2013 年到 2022 年,报告的堕胎总数减少了 5%(从 640 154 例减少到 640 154 例),堕胎率下降了 10%(从每千名 15-44 岁妇女 12.4 例堕胎减少到每千名 15-44 岁妇女 12.4 例堕胎),堕胎率上升了 1%(从每千名活产婴儿 198 例堕胎上升到每千名活产婴儿 198 例堕胎)。20-24 岁和 25-29 岁妇女的堕胎比例最高(分别为 28.3% 和 28.2%),堕胎率也最高(每千名 20-24 岁和 25-29 岁妇女的堕胎率分别为 18.1 和 18.7)。相比之下,妊娠 13 周的青少年堕胎率仍然较低(≤8.7%)。2022 年,妊娠≤9 周的早期药物流产所占比例最高(53.3%),其次是妊娠≤13 周的手术流产(35.5%)、妊娠>13 周的手术流产(6.9%)和妊娠>9 周的药物流产(4.3%);所有其他方法都不常见(解释:在 47 个连续报告数据的地区中,妊娠≤9 周的早期药物流产所占比例最高(53.3%),其次是妊娠≤13 周的手术流产(35.5%)、妊娠>13 周的手术流产(6.9%)和妊娠>9 周的药物流产(4.3%):在2013-2022年期间连续报告数据的47个地区中,观察到在此期间报告的堕胎数量和比率总体下降,堕胎比率上升;此外,从2021年到2022年,观察到所有措施均下降2%-3%:流产监测可用于帮助评估旨在促进美国公平获得以患者为中心的优质避孕服务的计划,以减少意外怀孕。
{"title":"Abortion Surveillance - United States, 2022.","authors":"Stephanie Ramer, Antoinette T Nguyen, Lisa M Hollier, Jessica Rodenhizer, Lee Warner, Maura K Whiteman","doi":"10.15585/mmwr.ss7307a1","DOIUrl":"10.15585/mmwr.ss7307a1","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Problem/condition: &lt;/strong&gt;CDC conducts abortion surveillance to document the number and characteristics of women obtaining legal induced abortions and the number of abortion-related deaths in the United States.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Period covered: &lt;/strong&gt;2022.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Description of system: &lt;/strong&gt;Each year, CDC requests abortion data from the central health agencies for the 50 states, the District of Columbia, and New York City. For 2022, a total of 48 reporting areas voluntarily provided aggregate abortion data to CDC. Of these, 47 reporting areas provided data each year during 2013-2022. Census and natality data were used to calculate abortion rates (number of abortions per 1,000 women aged 15-44 years) and ratios (number of abortions per 1,000 live births), respectively. Abortion-related deaths from 2021 were assessed as part of CDC's Pregnancy Mortality Surveillance System (PMSS).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;For 2022, a total of 613,383 abortions were reported to CDC from 48 reporting areas. Among 47 reporting areas with data each year during 2013-2022, in 2022, a total of 609,360 abortions were reported, the abortion rate was 11.2 abortions per 1,000 women aged 15-44 years, and the abortion ratio was 199 abortions per 1,000 live births. From 2021 to 2022, the total number of abortions decreased 2% (from 622,108 total abortions), the abortion rate decreased 3% (from 11.6 abortions per 1,000 women aged 15-44 years), and the abortion ratio decreased 2% (from 204 abortions per 1,000 live births). From 2013 to 2022, the total number of reported abortions decreased 5% (from 640,154), the abortion rate decreased 10% (from 12.4 abortions per 1,000 women aged 15-44 years), and the abortion ratio increased 1% (from 198 abortions per 1,000 live births).In 2022, women in their 20s accounted for more than half of abortions (56.5%). Women aged 20-24 and 25-29 years accounted for the highest percentages of abortions (28.3% and 28.2%, respectively) and had the highest abortion rates (18.1 and 18.7 abortions per 1,000 women aged 20-24 and 25-29 years, respectively). By contrast, adolescents aged &lt;15 years and women aged ≥40 years accounted for the lowest percentages of abortions (0.2% and 3.6%, respectively) and had the lowest abortion rates (0.4 and 2.5 abortions per 1,000 women aged &lt;15 and ≥40 years, respectively). However, abortion ratios were highest among adolescents (aged ≤19 years) and lowest among women aged 30-39 years.From 2021 to 2022, abortion rates decreased among women aged ≥20 years and did not change among adolescents (aged ≤19 years). Abortion rates decreased from 2013 to 2022 among all age groups, except women aged 30-34 years for whom it increased. The decrease in the abortion rate from 2013 to 2022 was highest among adolescents compared with other age groups. From 2021 to 2022, abortion ratios increased for adolescents and decreased among women aged ≥20 years. From 2013 to 2022, abortion ratios increased among adoles","PeriodicalId":48549,"journal":{"name":"Mmwr Surveillance Summaries","volume":"73 7","pages":"1-28"},"PeriodicalIF":37.3,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11616987/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142741000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laboratory-Confirmed Influenza-Associated Hospitalizations Among Children and Adults - Influenza Hospitalization Surveillance Network, United States, 2010-2023. 实验室确诊的儿童和成人流感相关住院病例 - 流感住院监测网络,美国,2010-2023 年。
IF 37.3 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-10-31 DOI: 10.15585/mmwr.ss7706a1
Angelle Naquin, Alissa O'Halloran, Dawud Ujamaa, Devi Sundaresan, Svetlana Masalovich, Charisse N Cummings, Kameela Noah, Seema Jain, Pam Daily Kirley, Nisha B Alden, Elizabeth Austin, James Meek, Kimberly Yousey-Hindes, Kyle Openo, Lucy Witt, Maya L Monroe, Justin Henderson, Val Tellez Nunez, Ruth Lynfield, Melissa McMahon, Yomei P Shaw, Caroline McCahon, Nancy Spina, Kerianne Engesser, Brenda L Tesini, Maria A Gaitan, Eli Shiltz, Krista Lung, Melissa Sutton, M Andraya Hendrick, William Schaffner, H Keipp Talbot, Andrea George, Hafsa Zahid, Carrie Reed, Shikha Garg, Catherine H Bozio
<p><strong>Problem/condition: </strong>Seasonal influenza accounts for 9.3 million-41 million illnesses, 100,000-710,000 hospitalizations, and 4,900-51,000 deaths annually in the United States. Since 2003, the Influenza Hospitalization Surveillance Network (FluSurv-NET) has been conducting population-based surveillance for laboratory-confirmed influenza-associated hospitalizations in the United States, including weekly rate estimations and descriptions of clinical characteristics and outcomes for hospitalized patients. However, a comprehensive summary of trends in hospitalization rates and clinical data collected from the surveillance platform has not been available.</p><p><strong>Reporting period: </strong>2010-11 through 2022-23 influenza seasons.</p><p><strong>Description of system: </strong>FluSurv-NET conducts population-based surveillance for laboratory-confirmed influenza-associated hospitalizations among children and adults. During the reporting period, the surveillance network included 13-16 participating sites each influenza season, with prespecified geographic catchment areas that covered 27 million-29 million persons and included an estimated 8.8%-9.5% of the U.S. population. A case was defined as a person residing in the catchment area within one of the participating states who had a positive influenza laboratory test result within 14 days before or at any time during their hospitalization. Each site abstracted case data from hospital medical records into a standardized case report form, with selected variables submitted to CDC on a weekly basis for rate estimations. Weekly and cumulative laboratory-confirmed influenza-associated hospitalization rates per 100,000 population were calculated for each season from 2010-11 through 2022-23 and stratified by patient age (0-4 years, 5-17 years, 18-49 years, 50-64 years, and ≥65 years), sex, race and ethnicity, influenza type, and influenza A subtype. During the 2020-21 season, only the overall influenza hospitalization rate was reported because case counts were insufficient to estimate stratified rates.</p><p><strong>Results: </strong>During the 2010-11 to 2022-23 influenza seasons, laboratory-confirmed influenza-associated hospitalization rates varied significantly across seasons. Before the COVID-19 pandemic, hospitalization rates per 100,000 population ranged from 8.7 (2011-12) to 102.9 (2017-18) and had consistent seasonality. After SARS-CoV-2 emerged, the hospitalization rate for 2020-21 was 0.8, and the rate did not return to recent prepandemic levels until 2022-23. Inconsistent seasonality also was observed during 2020-21 through 2022-23, with influenza activity being very low during 2020-21, extending later than usual during 2021-22, and occurring early during 2022-23. Molecular assays, particularly multiplex standard molecular assays, were the most common influenza test type in recent seasons, increasing from 12% during 2017-18 for both pediatric and adult cases to 43% and 55% durin
在所有入院患者中进行流感筛查)可能会对发现住院患者中的流感感染产生影响。抗病毒药物的使用在最近几个季节有所减少,应进一步评估减少的原因:公共卫生行动:继续加强流感监测对于监测鼓励抗病毒治疗和改善流感住院患者临床治疗效果的工作进展至关重要。此外,强有力的流感监测还可以为增加流感预防措施的使用提供信息,并监测住院率的任何后续变化,从而有可能减少差异。
{"title":"Laboratory-Confirmed Influenza-Associated Hospitalizations Among Children and Adults - Influenza Hospitalization Surveillance Network, United States, 2010-2023.","authors":"Angelle Naquin, Alissa O'Halloran, Dawud Ujamaa, Devi Sundaresan, Svetlana Masalovich, Charisse N Cummings, Kameela Noah, Seema Jain, Pam Daily Kirley, Nisha B Alden, Elizabeth Austin, James Meek, Kimberly Yousey-Hindes, Kyle Openo, Lucy Witt, Maya L Monroe, Justin Henderson, Val Tellez Nunez, Ruth Lynfield, Melissa McMahon, Yomei P Shaw, Caroline McCahon, Nancy Spina, Kerianne Engesser, Brenda L Tesini, Maria A Gaitan, Eli Shiltz, Krista Lung, Melissa Sutton, M Andraya Hendrick, William Schaffner, H Keipp Talbot, Andrea George, Hafsa Zahid, Carrie Reed, Shikha Garg, Catherine H Bozio","doi":"10.15585/mmwr.ss7706a1","DOIUrl":"10.15585/mmwr.ss7706a1","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Problem/condition: &lt;/strong&gt;Seasonal influenza accounts for 9.3 million-41 million illnesses, 100,000-710,000 hospitalizations, and 4,900-51,000 deaths annually in the United States. Since 2003, the Influenza Hospitalization Surveillance Network (FluSurv-NET) has been conducting population-based surveillance for laboratory-confirmed influenza-associated hospitalizations in the United States, including weekly rate estimations and descriptions of clinical characteristics and outcomes for hospitalized patients. However, a comprehensive summary of trends in hospitalization rates and clinical data collected from the surveillance platform has not been available.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Reporting period: &lt;/strong&gt;2010-11 through 2022-23 influenza seasons.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Description of system: &lt;/strong&gt;FluSurv-NET conducts population-based surveillance for laboratory-confirmed influenza-associated hospitalizations among children and adults. During the reporting period, the surveillance network included 13-16 participating sites each influenza season, with prespecified geographic catchment areas that covered 27 million-29 million persons and included an estimated 8.8%-9.5% of the U.S. population. A case was defined as a person residing in the catchment area within one of the participating states who had a positive influenza laboratory test result within 14 days before or at any time during their hospitalization. Each site abstracted case data from hospital medical records into a standardized case report form, with selected variables submitted to CDC on a weekly basis for rate estimations. Weekly and cumulative laboratory-confirmed influenza-associated hospitalization rates per 100,000 population were calculated for each season from 2010-11 through 2022-23 and stratified by patient age (0-4 years, 5-17 years, 18-49 years, 50-64 years, and ≥65 years), sex, race and ethnicity, influenza type, and influenza A subtype. During the 2020-21 season, only the overall influenza hospitalization rate was reported because case counts were insufficient to estimate stratified rates.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;During the 2010-11 to 2022-23 influenza seasons, laboratory-confirmed influenza-associated hospitalization rates varied significantly across seasons. Before the COVID-19 pandemic, hospitalization rates per 100,000 population ranged from 8.7 (2011-12) to 102.9 (2017-18) and had consistent seasonality. After SARS-CoV-2 emerged, the hospitalization rate for 2020-21 was 0.8, and the rate did not return to recent prepandemic levels until 2022-23. Inconsistent seasonality also was observed during 2020-21 through 2022-23, with influenza activity being very low during 2020-21, extending later than usual during 2021-22, and occurring early during 2022-23. Molecular assays, particularly multiplex standard molecular assays, were the most common influenza test type in recent seasons, increasing from 12% during 2017-18 for both pediatric and adult cases to 43% and 55% durin","PeriodicalId":48549,"journal":{"name":"Mmwr Surveillance Summaries","volume":"73 6","pages":"1-18"},"PeriodicalIF":37.3,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11537671/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142548437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surveillance for Violent Deaths - National Violent Death Reporting System, 48 States, the District of Columbia, and Puerto Rico, 2021. 暴力死亡监测--全国暴力死亡报告系统,48 个州、哥伦比亚特区和波多黎各,2021 年。
IF 37.3 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-07-11 DOI: 10.15585/mmwr.ss7305a1
Brenda L Nguyen, Bridget H Lyons, Kaitlin Forsberg, Rebecca F Wilson, Grace S Liu, Carter J Betz, Janet M Blair
<p><strong>Problem/condition: </strong>In 2021, approximately 75,000 persons died of violence-related injuries in the United States. This report summarizes data from CDC's National Violent Death Reporting System (NVDRS) on violent deaths that occurred in 48 states, the District of Columbia, and Puerto Rico in 2021. Results are reported by sex, age group, race and ethnicity, method of injury, type of location where the injury occurred, circumstances of injury, and other selected characteristics. This report introduces additional incident and circumstance variables, which now include child victim-specific circumstance information. This report also incorporates new U.S. Census Bureau race and ethnicity categories, which now account for more than one race and Native Hawaiian or other Pacific Islander categories and include updated denominators to calculate rates for these populations.</p><p><strong>Period covered: </strong>2021.</p><p><strong>Description of system: </strong>NVDRS collects data regarding violent deaths from death certificates, coroner and medical examiner records, and law enforcement reports. This report includes data collected for violent deaths that occurred in 2021. Data were collected from 48 states (all states with exception of Florida and Hawaii), the District of Columbia, and Puerto Rico. Forty-six states had statewide data, two additional states had data from counties representing a subset of their population (31 California counties, representing 64% of its population, and 13 Texas counties, representing 63% of its population), and the District of Columbia and Puerto Rico had jurisdiction-wide data. NVDRS collates information for each violent death and links deaths that are related (e.g., multiple homicides, homicide followed by suicide, or multiple suicides) into a single incident.</p><p><strong>Results: </strong>For 2021, NVDRS collected information on 68,866 fatal incidents involving 70,688 deaths that occurred in 48 states (46 states collecting statewide data, 31 California counties, and 13 Texas counties), and the District of Columbia. The deaths captured in NVDRS accounted for 86.5% of all homicides, legal intervention deaths, suicides, unintentional firearm injury deaths, and deaths of undetermined intent in the United States in 2021. In addition, information was collected for 816 fatal incidents involving 880 deaths in Puerto Rico. Data for Puerto Rico were analyzed separately. Of the 70,688 deaths, the majority (58.2%) were suicides, followed by homicides (31.5%), deaths of undetermined intent that might be due to violence (8.2%), legal intervention deaths (1.3%) (i.e., deaths caused by law enforcement and other persons with legal authority to use deadly force acting in the line of duty, excluding legal executions), and unintentional firearm injury deaths (<1.0%). The term "legal intervention" is a classification incorporated into the International Classification of Diseases, Tenth Revision, and does not denote the la
问题/条件:2021 年,美国约有 75,000 人死于与暴力有关的伤害。本报告总结了美国疾病预防控制中心全国暴力死亡报告系统 (NVDRS) 提供的 2021 年发生在美国 48 个州、哥伦比亚特区和波多黎各的暴力死亡数据。报告结果按性别、年龄组、种族和民族、伤害方式、伤害发生地类型、伤害情况和其他选定特征分列。本报告引入了更多的事件和情况变量,其中现在包括儿童受害者的具体情况信息。本报告还纳入了美国人口普查局新的种族和人种类别,现在这些类别包括多个种族和夏威夷原住民或其他太平洋岛民类别,并包括用于计算这些人群比率的最新分母:NVDRS 从死亡证明、验尸官和法医记录以及执法报告中收集有关暴力死亡的数据。本报告包括收集到的 2021 年发生的暴力死亡数据。数据收集自 48 个州(除佛罗里达州和夏威夷州外的所有州)、哥伦比亚特区和波多黎各。46 个州提供了全州数据,另外两个州提供了代表其人口子集的县的数据(加利福尼亚州 31 个县,占其人口的 64%,得克萨斯州 13 个县,占其人口的 63%),哥伦比亚特区和波多黎各提供了整个辖区的数据。NVDRS 整理了每起暴力死亡事件的信息,并将相关死亡事件(如多起凶杀、凶杀后自杀或多起自杀)链接为一起事件:2021 年,NVDRS 收集了 48 个州(46 个州收集全州数据,31 个加利福尼亚州县和 13 个得克萨斯州县)和哥伦比亚特区发生的 68,866 起死亡事件的信息,涉及 70,688 例死亡。NVDRS 采集的死亡人数占 2021 年美国所有凶杀、法律干预死亡、自杀、意外枪支伤害死亡和意图不明死亡人数的 86.5%。此外,还收集了波多黎各涉及 880 人死亡的 816 起死亡事件的信息。对波多黎各的数据进行了单独分析。在 70,688 例死亡中,大多数(58.2%)是自杀,其次是他杀(31.5%)、可能因暴力导致的意图不明的死亡(8.2%)、合法干预死亡(1.3%)(即执法人员和其他有合法权力使用致命武力的人员在执行公务时造成的死亡,不包括合法处决),以及非故意枪支伤害死亡(解释:"非故意枪支伤害死亡 "是指在执行公务时使用致命武力造成的死亡:本报告详细总结了 NVDRS 提供的 2021 年发生的暴力死亡数据。亚裔美国人/印第安人和白人男性的自杀率最高,而黑人男性的凶杀率最高。在女性凶杀案中,亲密伴侣暴力占很大比例。心理健康问题、亲密伴侣问题、人际冲突和严重的生活压力是多种类型死亡的主要诱发因素:暴力是可以预防的,数据可以指导公共卫生行动。NVDRS 数据用于监测与暴力有关的致命伤害的发生情况,并协助公共卫生机构制定、实施和评估旨在减少和预防暴力致死的计划、政策和实践。NVDRS 数据可用于加强预防工作,将其转化为可操作的战略。各州或辖区已使用其暴力死亡报告系统 (VDRS) 数据来指导自杀预防工作,并强调需要额外关注的地方。例如,北卡罗来纳州的暴力死亡报告系统计划数据在扩大与枪支安全和伤害预防相关的活动方面发挥了重要作用。该计划作为合作伙伴的主要数据来源,促使该州成立了暴力预防办公室,重点打击与枪支相关的死亡事件。在缅因州,VDRS 提供了有关执法人员自杀的数据,这些数据被用来帮助支持一项法案,该法案规定在该州的执法培训学院中开展心理健康复原力和意识培训,并计划在惩教人员中开展类似的培训,以解决心理健康、药物使用和酗酒问题。此外,各州和辖区还利用其 VDRS 数据来研究本州或辖区内与凶杀案有关的因素。例如,佐治亚州 VDRS 与亚特兰大市市长减少暴力办公室合作开发了两个公共仪表板,不仅提供了有关暴力死亡的综合数据,还提供了受暴力影响严重的人口地理分布数据,以帮助为暴力预防干预措施提供信息。
{"title":"Surveillance for Violent Deaths - National Violent Death Reporting System, 48 States, the District of Columbia, and Puerto Rico, 2021.","authors":"Brenda L Nguyen, Bridget H Lyons, Kaitlin Forsberg, Rebecca F Wilson, Grace S Liu, Carter J Betz, Janet M Blair","doi":"10.15585/mmwr.ss7305a1","DOIUrl":"10.15585/mmwr.ss7305a1","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Problem/condition: &lt;/strong&gt;In 2021, approximately 75,000 persons died of violence-related injuries in the United States. This report summarizes data from CDC's National Violent Death Reporting System (NVDRS) on violent deaths that occurred in 48 states, the District of Columbia, and Puerto Rico in 2021. Results are reported by sex, age group, race and ethnicity, method of injury, type of location where the injury occurred, circumstances of injury, and other selected characteristics. This report introduces additional incident and circumstance variables, which now include child victim-specific circumstance information. This report also incorporates new U.S. Census Bureau race and ethnicity categories, which now account for more than one race and Native Hawaiian or other Pacific Islander categories and include updated denominators to calculate rates for these populations.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Period covered: &lt;/strong&gt;2021.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Description of system: &lt;/strong&gt;NVDRS collects data regarding violent deaths from death certificates, coroner and medical examiner records, and law enforcement reports. This report includes data collected for violent deaths that occurred in 2021. Data were collected from 48 states (all states with exception of Florida and Hawaii), the District of Columbia, and Puerto Rico. Forty-six states had statewide data, two additional states had data from counties representing a subset of their population (31 California counties, representing 64% of its population, and 13 Texas counties, representing 63% of its population), and the District of Columbia and Puerto Rico had jurisdiction-wide data. NVDRS collates information for each violent death and links deaths that are related (e.g., multiple homicides, homicide followed by suicide, or multiple suicides) into a single incident.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;For 2021, NVDRS collected information on 68,866 fatal incidents involving 70,688 deaths that occurred in 48 states (46 states collecting statewide data, 31 California counties, and 13 Texas counties), and the District of Columbia. The deaths captured in NVDRS accounted for 86.5% of all homicides, legal intervention deaths, suicides, unintentional firearm injury deaths, and deaths of undetermined intent in the United States in 2021. In addition, information was collected for 816 fatal incidents involving 880 deaths in Puerto Rico. Data for Puerto Rico were analyzed separately. Of the 70,688 deaths, the majority (58.2%) were suicides, followed by homicides (31.5%), deaths of undetermined intent that might be due to violence (8.2%), legal intervention deaths (1.3%) (i.e., deaths caused by law enforcement and other persons with legal authority to use deadly force acting in the line of duty, excluding legal executions), and unintentional firearm injury deaths (&lt;1.0%). The term \"legal intervention\" is a classification incorporated into the International Classification of Diseases, Tenth Revision, and does not denote the la","PeriodicalId":48549,"journal":{"name":"Mmwr Surveillance Summaries","volume":"73 5","pages":"1-44"},"PeriodicalIF":37.3,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11262823/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141564863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progress Toward Tuberculosis Elimination and Tuberculosis Program Performance - National Tuberculosis Indicators Project, 2016-2022. 2016-2022年消除结核病进展和结核病计划绩效--国家结核病指标项目。
IF 37.3 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-06 DOI: 10.15585/mmwr.ss7304a1
Rachel Woodruff, Robert Pratt, Maureen Kolasa
<p><strong>Problem/condition: </strong>Elimination of tuberculosis (TB) is defined as reducing TB disease incidence in the United States to less than 1 case per million persons per year. In 2022, TB incidence in the United States was 2.5 TB cases per 100,000 persons. CDC's TB program developed a set of national TB indicators to evaluate progress toward TB elimination through monitoring performance of state and city TB program activities. Examining TB indicator data enables state- and city-level TB programs to identify areas for program evaluation and improvement activities. These data also help CDC identify states and cities that might benefit from technical assistance.</p><p><strong>Period covered: </strong>The 5-year period for which the most recent data were available for each of five indicators: 1) overall TB incidence (2018-2022), 2) TB incidence among non-U.S.-born persons (2018-2022), 3) percentage of persons with drug susceptibility results reported (2018-2022), 4) percentage of contacts to sputum acid-fast bacillus (AFB) smear-positive TB patients with newly diagnosed latent TB infection (LTBI) who completed treatment (2017-2021), and 5) percentage of patients with completion of TB therapy within 12 months (2016-2020).</p><p><strong>Description of system: </strong>The National TB Indicators Project (NTIP) is a web-based performance monitoring tool that uses national TB surveillance data reported through the National TB Surveillance System and the Aggregate Reports for TB Program Evaluation. NTIP was developed to facilitate the use of existing data to help TB program staff members prioritize activities, monitor progress, and focus program improvement efforts. The following five indicators were selected for this report because of their importance in Federal TB funding allocation and in accelerating the decline in TB cases: 1) overall TB incidence in the United States, 2) TB incidence among non-U.S.-born persons, 3) percentage of persons with drug susceptibility results reported, 4) percentage of contacts to sputum AFB smear-positive TB cases who completed treatment for LTBI, and 5) percentage of patients with completion of TB therapy within 12 months. For this report, 52 TB programs (50 states, the District of Columbia, and New York City) were categorized into terciles based on the 5-year average number of TB cases reported to National TB Surveillance System. This grouping allows comparison of TB programs that have similar numbers of TB cases and allocates a similar number of TB programs to each category. The following formula was used to calculate the relative change by TB program for each indicator: [(% from year 5 - % from year 1 ÷ % from year 1) × 100].</p><p><strong>Results: </strong>During the 5-year period for which the most recent data were available, most TB programs had improvements in reducing overall TB incidence (71.2%) and increasing the percentage of contacts receiving a diagnosis of LTBI who completed LTBI treatment (55.8%)
问题/条件:消灭结核病(TB)的定义是将美国每年每百万人中的结核病发病率降至 1 例以下。2022 年,美国的结核病发病率为每 10 万人 2.5 例。美国疾病预防控制中心结核病项目制定了一套国家结核病指标,通过监测各州市结核病项目活动的绩效来评估消除结核病的进展情况。通过检查结核病指标数据,州和城市一级的结核病计划能够确定计划评估和改进活动的领域。这些数据还有助于疾病预防控制中心确定可能从技术援助中受益的州和城市:五项指标中每项指标都有最新数据的五年期:1)总体结核病发病率(2018-2022 年);2)非美国出生者的结核病发病率(2018-2022 年);3)报告药物敏感性结果者的百分比(2018-2022 年);4)与新诊断为潜伏肺结核感染(LTBI)的痰酸性ast bacillus(AFB)涂片阳性肺结核患者接触并完成治疗者的百分比(2017-2021 年);5)在 12 个月内完成结核病治疗者的百分比(2016-2020 年):国家结核病指标项目(NTIP)是一个基于网络的绩效监测工具,它使用通过国家结核病监测系统(National TB Surveillance System)和结核病项目评估汇总报告(Aggregate Reports for TB Program Evaluation)报告的国家结核病监测数据。开发 NTIP 的目的是促进现有数据的使用,以帮助结核病项目工作人员确定活动的优先次序、监控进展情况并集中精力改进项目。本报告选择了以下五个指标,因为它们在联邦结核病资金分配和加速结核病病例减少方面具有重要意义:1) 美国结核病的总体发病率;2) 非美国出生者中的结核病发病率;3) 报告药物敏感性结果者的百分比;4) 痰 AFB 涂片阳性结核病病例的接触者中完成长期肺结核治疗者的百分比;5) 在 12 个月内完成结核病治疗者的百分比。在本报告中,52 个结核病防治项目(50 个州、哥伦比亚特区和纽约市)根据向国家结核病监测系统报告的 5 年平均结核病例数被分为三等。通过这种分组方式,可以对结核病例数量相近的结核病计划进行比较,并将数量相近的结核病计划分配到每个类别中。以下公式用于计算各结核病项目在各项指标上的相对变化:[结果:结果:在有最新数据可查的 5 年期间,大多数结核病防治项目在降低总体结核病发病率(71.2%)和提高接触者中被确诊为迟发性肺结核并完成迟发性肺结核治疗者的比例(55.8%)方面都有所改善;大多数项目(51.0%)在降低非美国出生者的发病率方面也有所改善。大多数辖区(52个辖区中的28个,[53.9%])报告的药物敏感性结果的平均百分比达到或超过了5年全国平均水平97%(2018-2022年)。从 2017 年到 2021 年,52 个辖区中有 29 个辖区(55.8%)新诊断为潜伏肺结核感染(LTBI)的痰酸性ast bacillus(AFB)涂片阳性肺结核患者的接触者完成治疗的百分比有所增加,这表明大多数辖区已采取措施提高这方面的绩效。约三分之二的辖区(52 个辖区中的 32 个[61.5%])在 12 个月内完成结核病治疗的患者平均比例达到或超过 89.7% 的全国平均水平:本报告首次描述了肺结核项目绩效的 5 年相对变化。这些结果表明,肺结核项目在帮助识别肺结核和迟发性肺结核患者并确保患者及时完成治疗的活动方面正在取得进展:公共卫生行动:使用来自各个结核病项目的 NTIP 数据可以更详细地检查项目绩效的趋势,并确定项目改进的领域。通过评估结核病项目的指标趋势,可以更好地了解与其他项目相比的项目绩效。它还能促进项目之间就项目改进中的成功与挑战进行交流。这些信息对结核病项目有效分配资源很有价值,并为公共卫生决策者提供了更多有关结核病控制的信息。
{"title":"Progress Toward Tuberculosis Elimination and Tuberculosis Program Performance - National Tuberculosis Indicators Project, 2016-2022.","authors":"Rachel Woodruff, Robert Pratt, Maureen Kolasa","doi":"10.15585/mmwr.ss7304a1","DOIUrl":"10.15585/mmwr.ss7304a1","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Problem/condition: &lt;/strong&gt;Elimination of tuberculosis (TB) is defined as reducing TB disease incidence in the United States to less than 1 case per million persons per year. In 2022, TB incidence in the United States was 2.5 TB cases per 100,000 persons. CDC's TB program developed a set of national TB indicators to evaluate progress toward TB elimination through monitoring performance of state and city TB program activities. Examining TB indicator data enables state- and city-level TB programs to identify areas for program evaluation and improvement activities. These data also help CDC identify states and cities that might benefit from technical assistance.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Period covered: &lt;/strong&gt;The 5-year period for which the most recent data were available for each of five indicators: 1) overall TB incidence (2018-2022), 2) TB incidence among non-U.S.-born persons (2018-2022), 3) percentage of persons with drug susceptibility results reported (2018-2022), 4) percentage of contacts to sputum acid-fast bacillus (AFB) smear-positive TB patients with newly diagnosed latent TB infection (LTBI) who completed treatment (2017-2021), and 5) percentage of patients with completion of TB therapy within 12 months (2016-2020).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Description of system: &lt;/strong&gt;The National TB Indicators Project (NTIP) is a web-based performance monitoring tool that uses national TB surveillance data reported through the National TB Surveillance System and the Aggregate Reports for TB Program Evaluation. NTIP was developed to facilitate the use of existing data to help TB program staff members prioritize activities, monitor progress, and focus program improvement efforts. The following five indicators were selected for this report because of their importance in Federal TB funding allocation and in accelerating the decline in TB cases: 1) overall TB incidence in the United States, 2) TB incidence among non-U.S.-born persons, 3) percentage of persons with drug susceptibility results reported, 4) percentage of contacts to sputum AFB smear-positive TB cases who completed treatment for LTBI, and 5) percentage of patients with completion of TB therapy within 12 months. For this report, 52 TB programs (50 states, the District of Columbia, and New York City) were categorized into terciles based on the 5-year average number of TB cases reported to National TB Surveillance System. This grouping allows comparison of TB programs that have similar numbers of TB cases and allocates a similar number of TB programs to each category. The following formula was used to calculate the relative change by TB program for each indicator: [(% from year 5 - % from year 1 ÷ % from year 1) × 100].&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;During the 5-year period for which the most recent data were available, most TB programs had improvements in reducing overall TB incidence (71.2%) and increasing the percentage of contacts receiving a diagnosis of LTBI who completed LTBI treatment (55.8%)","PeriodicalId":48549,"journal":{"name":"Mmwr Surveillance Summaries","volume":"73 4","pages":"1-18"},"PeriodicalIF":37.3,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11166372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141248751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sentinel Enhanced Dengue Surveillance System - Puerto Rico, 2012-2022. 哨点强化登革热监测系统 - 波多黎各,2012-2022 年。
IF 37.3 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-05-30 DOI: 10.15585/mmwr.ss7303a1
Zachary J Madewell, Alfonso C Hernandez-Romieu, Joshua M Wong, Laura D Zambrano, Hannah R Volkman, Janice Perez-Padilla, Dania M Rodriguez, Olga Lorenzi, Carla Espinet, Jorge Munoz-Jordan, Verónica M Frasqueri-Quintana, Vanessa Rivera-Amill, Luisa I Alvarado-Domenech, Diego Sainz, Jorge Bertran, Gabriela Paz-Bailey, Laura E Adams
<p><strong>Problem/condition: </strong>Dengue is the most prevalent mosquitoborne viral illness worldwide and is endemic in Puerto Rico. Dengue's clinical spectrum can range from mild, undifferentiated febrile illness to hemorrhagic manifestations, shock, multiorgan failure, and death in severe cases. The disease presentation is nonspecific; therefore, various other illnesses (e.g., arboviral and respiratory pathogens) can cause similar clinical symptoms. Enhanced surveillance is necessary to determine disease prevalence, to characterize the epidemiology of severe disease, and to evaluate diagnostic and treatment practices to improve patient outcomes. The Sentinel Enhanced Dengue Surveillance System (SEDSS) was established to monitor trends of dengue and dengue-like acute febrile illnesses (AFIs), characterize the clinical course of disease, and serve as an early warning system for viral infections with epidemic potential.</p><p><strong>Reporting period: </strong>May 2012-December 2022.</p><p><strong>Description of system: </strong>SEDSS conducts enhanced surveillance for dengue and other relevant AFIs in Puerto Rico. This report includes aggregated data collected from May 2012 through December 2022. SEDSS was launched in May 2012 with patients with AFIs from five health care facilities enrolled. The facilities included two emergency departments in tertiary acute care hospitals in the San Juan-Caguas-Guaynabo metropolitan area and Ponce, two secondary acute care hospitals in Carolina and Guayama, and one outpatient acute care clinic in Ponce. Patients arriving at any SEDSS site were eligible for enrollment if they reported having fever within the past 7 days. During the Zika epidemic (June 2016-June 2018), patients were eligible for enrollment if they had either rash and conjunctivitis, rash and arthralgia, or fever. Eligibility was expanded in April 2020 to include reported cough or shortness of breath within the past 14 days. Blood, urine, nasopharyngeal, and oropharyngeal specimens were collected at enrollment from all participants who consented. Diagnostic testing for dengue virus (DENV) serotypes 1-4, chikungunya virus, Zika virus, influenza A and B viruses, SARS-CoV-2, and five other respiratory viruses was performed by the CDC laboratory in San Juan.</p><p><strong>Results: </strong>During May 2012-December 2022, a total of 43,608 participants with diagnosed AFI were enrolled in SEDSS; a majority of participants (45.0%) were from Ponce. During the surveillance period, there were 1,432 confirmed or probable cases of dengue, 2,293 confirmed or probable cases of chikungunya, and 1,918 confirmed or probable cases of Zika. The epidemic curves of the three arboviruses indicate dengue is endemic; outbreaks of chikungunya and Zika were sporadic, with case counts peaking in late 2014 and 2016, respectively. The majority of commonly identified respiratory pathogens were influenza A virus (3,756), SARS-CoV-2 (1,586), human adenovirus (1,550), respirat
问题/条件:登革热是全球最流行的蚊媒病毒性疾病,在波多黎各呈地方性流行。登革热的临床表现范围很广,从轻微、无差别的发热性疾病到出血性表现、休克、多器官功能衰竭,严重者甚至死亡。登革热的症状没有特异性,因此其他各种疾病(如虫媒病毒和呼吸道病原体)也会引起类似的临床症状。有必要加强监测,以确定疾病的流行情况,描述严重疾病的流行病学特征,并评估诊断和治疗方法,从而改善患者的预后。建立登革热哨点强化监测系统(SEDSS)的目的是监测登革热和登革热样急性发热性疾病(AFIs)的发病趋势,描述疾病的临床过程,并作为具有流行潜力的病毒感染的预警系统:报告期:2012 年 5 月至 2022 年 12 月:SEDSS 对波多黎各的登革热和其他相关 AFI 进行强化监测。本报告包括从 2012 年 5 月至 2022 年 12 月收集的汇总数据。SEDSS 于 2012 年 5 月启动,五个医疗机构的 AFI 患者加入了该系统。这些医疗机构包括位于圣胡安-瓜瓜斯-瓜伊纳布大都会区和庞塞的两家三级急症医院的急诊科、位于卡罗莱纳和瓜亚马的两家二级急症医院以及位于庞塞的一家急症门诊诊所。到达任何一个 SEDSS 站点的患者只要报告在过去 7 天内发烧,就有资格加入。在寨卡疫情期间(2016 年 6 月至 2018 年 6 月),如果患者出现皮疹和结膜炎、皮疹和关节痛或发热,则有资格加入。2020 年 4 月,资格范围扩大到包括过去 14 天内报告的咳嗽或呼吸急促。所有同意的参与者在入组时均采集了血液、尿液、鼻咽和口咽标本。登革热病毒(DENV)血清型 1-4、基孔肯雅病毒、寨卡病毒、甲型和乙型流感病毒、SARS-CoV-2 以及其他五种呼吸道病毒的诊断检测由圣胡安的疾病预防控制中心实验室进行:2012 年 5 月至 2022 年 12 月期间,SEDSS 共登记了 43 608 名确诊为 AFI 的参与者;其中大部分参与者(45.0%)来自庞塞。在监测期间,共有 1,432 例登革热确诊或疑似病例,2,293 例基孔肯雅确诊或疑似病例,1,918 例寨卡确诊或疑似病例。这三种虫媒病毒的流行曲线表明,登革热呈地方性流行;基孔肯雅和寨卡病毒的爆发是零星的,病例数分别在 2014 年末和 2016 年达到高峰。大多数常见的呼吸道病原体是甲型流感病毒(3756 例)、SARS-CoV-2(1586 例)、人类腺病毒(1550 例)、呼吸道合胞病毒(1489 例)、乙型流感病毒(1430 例)和人类副流感病毒 1 型或 3 型(1401 例)。共有 5,502 人确诊或可能感染了虫媒病毒,11,922 人确诊感染了呼吸道病毒,26,503 人感染了 AFI,但没有感染任何虫媒病毒或呼吸道病毒:登革热在波多黎各呈地方性流行;然而,在报告所述期间,发病率变化很大,最近一次显著爆发发生在 2012-2013 年。在监测期间,DENV-1 是主要的病毒;也有零星的 DENV-4 病例报告。波多黎各在 2014 年和 2016 年分别经历了基孔肯雅病毒和寨卡病毒的大规模爆发,前者在 2014 年达到高峰,后者在 2016 年达到高峰;此后这两种病毒的病例报告很少。甲型流感和呼吸道合胞病毒的季节性模式截然不同,呼吸道合胞病毒的发病率通常比甲型流感早几周达到年度高峰:SEDSS 是唯一一个以站点为基础的强化监测系统,旨在收集波多黎各 AFI 病例的信息。本报告说明,SEDSS 可用于检测登革热、寨卡、基孔肯雅、COVID-19 和流感爆发以及其他季节性急性呼吸道病毒,强调了识别相关疾病的体征和症状以及了解这些病毒之间传播动态的重要性。本报告还介绍了疾病发病率的波动情况,强调了主动监测、急性呼吸道病毒检测组的价值,以及灵活、反应迅速的监测系统在应对不断变化的公共卫生挑战方面的重要性。波多黎各正在考虑或实施各种病媒控制策略和疫苗,可能会整合正在进行的试验和 SEDSS 的数据,以更好地了解传播的流行病学因素和风险缓解方法。
{"title":"Sentinel Enhanced Dengue Surveillance System - Puerto Rico, 2012-2022.","authors":"Zachary J Madewell, Alfonso C Hernandez-Romieu, Joshua M Wong, Laura D Zambrano, Hannah R Volkman, Janice Perez-Padilla, Dania M Rodriguez, Olga Lorenzi, Carla Espinet, Jorge Munoz-Jordan, Verónica M Frasqueri-Quintana, Vanessa Rivera-Amill, Luisa I Alvarado-Domenech, Diego Sainz, Jorge Bertran, Gabriela Paz-Bailey, Laura E Adams","doi":"10.15585/mmwr.ss7303a1","DOIUrl":"10.15585/mmwr.ss7303a1","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Problem/condition: &lt;/strong&gt;Dengue is the most prevalent mosquitoborne viral illness worldwide and is endemic in Puerto Rico. Dengue's clinical spectrum can range from mild, undifferentiated febrile illness to hemorrhagic manifestations, shock, multiorgan failure, and death in severe cases. The disease presentation is nonspecific; therefore, various other illnesses (e.g., arboviral and respiratory pathogens) can cause similar clinical symptoms. Enhanced surveillance is necessary to determine disease prevalence, to characterize the epidemiology of severe disease, and to evaluate diagnostic and treatment practices to improve patient outcomes. The Sentinel Enhanced Dengue Surveillance System (SEDSS) was established to monitor trends of dengue and dengue-like acute febrile illnesses (AFIs), characterize the clinical course of disease, and serve as an early warning system for viral infections with epidemic potential.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Reporting period: &lt;/strong&gt;May 2012-December 2022.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Description of system: &lt;/strong&gt;SEDSS conducts enhanced surveillance for dengue and other relevant AFIs in Puerto Rico. This report includes aggregated data collected from May 2012 through December 2022. SEDSS was launched in May 2012 with patients with AFIs from five health care facilities enrolled. The facilities included two emergency departments in tertiary acute care hospitals in the San Juan-Caguas-Guaynabo metropolitan area and Ponce, two secondary acute care hospitals in Carolina and Guayama, and one outpatient acute care clinic in Ponce. Patients arriving at any SEDSS site were eligible for enrollment if they reported having fever within the past 7 days. During the Zika epidemic (June 2016-June 2018), patients were eligible for enrollment if they had either rash and conjunctivitis, rash and arthralgia, or fever. Eligibility was expanded in April 2020 to include reported cough or shortness of breath within the past 14 days. Blood, urine, nasopharyngeal, and oropharyngeal specimens were collected at enrollment from all participants who consented. Diagnostic testing for dengue virus (DENV) serotypes 1-4, chikungunya virus, Zika virus, influenza A and B viruses, SARS-CoV-2, and five other respiratory viruses was performed by the CDC laboratory in San Juan.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;During May 2012-December 2022, a total of 43,608 participants with diagnosed AFI were enrolled in SEDSS; a majority of participants (45.0%) were from Ponce. During the surveillance period, there were 1,432 confirmed or probable cases of dengue, 2,293 confirmed or probable cases of chikungunya, and 1,918 confirmed or probable cases of Zika. The epidemic curves of the three arboviruses indicate dengue is endemic; outbreaks of chikungunya and Zika were sporadic, with case counts peaking in late 2014 and 2016, respectively. The majority of commonly identified respiratory pathogens were influenza A virus (3,756), SARS-CoV-2 (1,586), human adenovirus (1,550), respirat","PeriodicalId":48549,"journal":{"name":"Mmwr Surveillance Summaries","volume":"73 3","pages":"1-29"},"PeriodicalIF":37.3,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11152364/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141162634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventable Premature Deaths from the Five Leading Causes of Death in Nonmetropolitan and Metropolitan Counties, United States, 2010-2022. 2010-2022 年美国非大都市和大都市郡五大主要死因中可预防的过早死亡。
IF 37.3 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-05-02 DOI: 10.15585/mmwr.ss7302a1
Macarena C García, Lauren M Rossen, Kevin Matthews, Gery Guy, Katrina F Trivers, Cheryll C Thomas, Linda Schieb, Michael F Iademarco
<p><strong>Problem/condition: </strong>A 2019 report quantified the higher percentage of potentially excess (preventable) deaths in U.S. nonmetropolitan areas compared with metropolitan areas during 2010-2017. In that report, CDC compared national, regional, and state estimates of preventable premature deaths from the five leading causes of death in nonmetropolitan and metropolitan counties during 2010-2017. This report provides estimates of preventable premature deaths for additional years (2010-2022).</p><p><strong>Period covered: </strong>2010-2022.</p><p><strong>Description of system: </strong>Mortality data for U.S. residents from the National Vital Statistics System were used to calculate preventable premature deaths from the five leading causes of death among persons aged <80 years. CDC's National Center for Health Statistics urban-rural classification scheme for counties was used to categorize the deaths according to the urban-rural county classification level of the decedent's county of residence (1: large central metropolitan [most urban], 2: large fringe metropolitan, 3: medium metropolitan, 4: small metropolitan, 5: micropolitan, and 6: noncore [most rural]). Preventable premature deaths were defined as deaths among persons aged <80 years that exceeded the number expected if the death rates for each cause in all states were equivalent to those in the benchmark states (i.e., the three states with the lowest rates). Preventable premature deaths were calculated separately for the six urban-rural county categories nationally, the 10 U.S. Department of Health and Human Services public health regions, and the 50 states and the District of Columbia.</p><p><strong>Results: </strong>During 2010-2022, the percentage of preventable premature deaths among persons aged <80 years in the United States increased for unintentional injury (e.g., unintentional poisoning including drug overdose, unintentional motor vehicle traffic crash, unintentional drowning, and unintentional fall) and stroke, decreased for cancer and chronic lower respiratory disease (CLRD), and remained stable for heart disease. The percentages of preventable premature deaths from the five leading causes of death were higher in rural counties in all years during 2010-2022. When assessed by the six urban-rural county classifications, percentages of preventable premature deaths in the most rural counties (noncore) were consistently higher than in the most urban counties (large central metropolitan and fringe metropolitan) for the five leading causes of death during the study period.During 2010-2022, preventable premature deaths from heart disease increased most in noncore (+9.5%) and micropolitan counties (+9.1%) and decreased most in large central metropolitan counties (-10.2%). Preventable premature deaths from cancer decreased in all county categories, with the largest decreases in large central metropolitan and large fringe metropolitan counties (-100.0%; benchmark achieved in bot
问题/条件:2019 年的一份报告量化了 2010-2017 年期间美国非大都市地区与大都市地区相比潜在超额(可预防)死亡的较高比例。在该报告中,疾病预防控制中心比较了 2010-2017 年期间国家、地区和州对非大都市县和大都市县五大死因造成的可预防过早死亡的估计值。本报告提供了更多年份(2010-2022 年)可预防的过早死亡估计值。覆盖时期:2010-2022 年:美国居民的死亡率数据来自国家人口动态统计系统,用于计算结果年龄段人群因五大死因造成的可预防的过早死亡:在 2010-2022 年期间,可预防的过早死亡在老年人中所占的百分比:在 2010-2022 年期间,非大城市县在五大死因中的可预防过早死亡比例高于全国、各公共卫生地区和大多数州的大城市县。在 2010-2022 年期间,就四种死因(癌症、心脏病、慢性肺部疾病和中风)而言,最偏远农村地区和最偏远城市地区之间在可预防的过早死亡方面的差距有所扩大,而在意外伤害方面的差距有所缩小。2010-2022 年期间,城市和郊区县(大型中心都市、大型边缘都市、中型都市和小型都市)可预防的意外伤害过早死亡人数有所增加,导致非核心县和微型都市县可预防的过早死亡人数比例已经很高(2022 年约为 69%),两者之间的差距缩小。2020 年,意外伤害、心脏病和中风导致的可预防的过早死亡急剧增加,而慢性阻塞性肺疾病和癌症导致的可预防的过早死亡继续下降。2017-2020 年间,CLRD 死亡率有所下降,但 2022 年有所上升。2020 年观察到多种主要死因的可预防过早死亡比例上升,这可能与 COVID-19 相关疾病有关,这些疾病导致心脏病和中风死亡率上升:公共卫生行动:根据城乡县级分类对可预防的过早死亡进行常规跟踪,可使公共卫生部门识别和监测健康结果的地域差异。这些差异可能与获得医疗保健的不同程度、健康的社会决定因素以及其他风险因素有关。确定潜在可预防死亡率较高的地区可能有助于采取干预措施。
{"title":"Preventable Premature Deaths from the Five Leading Causes of Death in Nonmetropolitan and Metropolitan Counties, United States, 2010-2022.","authors":"Macarena C García, Lauren M Rossen, Kevin Matthews, Gery Guy, Katrina F Trivers, Cheryll C Thomas, Linda Schieb, Michael F Iademarco","doi":"10.15585/mmwr.ss7302a1","DOIUrl":"10.15585/mmwr.ss7302a1","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Problem/condition: &lt;/strong&gt;A 2019 report quantified the higher percentage of potentially excess (preventable) deaths in U.S. nonmetropolitan areas compared with metropolitan areas during 2010-2017. In that report, CDC compared national, regional, and state estimates of preventable premature deaths from the five leading causes of death in nonmetropolitan and metropolitan counties during 2010-2017. This report provides estimates of preventable premature deaths for additional years (2010-2022).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Period covered: &lt;/strong&gt;2010-2022.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Description of system: &lt;/strong&gt;Mortality data for U.S. residents from the National Vital Statistics System were used to calculate preventable premature deaths from the five leading causes of death among persons aged &lt;80 years. CDC's National Center for Health Statistics urban-rural classification scheme for counties was used to categorize the deaths according to the urban-rural county classification level of the decedent's county of residence (1: large central metropolitan [most urban], 2: large fringe metropolitan, 3: medium metropolitan, 4: small metropolitan, 5: micropolitan, and 6: noncore [most rural]). Preventable premature deaths were defined as deaths among persons aged &lt;80 years that exceeded the number expected if the death rates for each cause in all states were equivalent to those in the benchmark states (i.e., the three states with the lowest rates). Preventable premature deaths were calculated separately for the six urban-rural county categories nationally, the 10 U.S. Department of Health and Human Services public health regions, and the 50 states and the District of Columbia.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;During 2010-2022, the percentage of preventable premature deaths among persons aged &lt;80 years in the United States increased for unintentional injury (e.g., unintentional poisoning including drug overdose, unintentional motor vehicle traffic crash, unintentional drowning, and unintentional fall) and stroke, decreased for cancer and chronic lower respiratory disease (CLRD), and remained stable for heart disease. The percentages of preventable premature deaths from the five leading causes of death were higher in rural counties in all years during 2010-2022. When assessed by the six urban-rural county classifications, percentages of preventable premature deaths in the most rural counties (noncore) were consistently higher than in the most urban counties (large central metropolitan and fringe metropolitan) for the five leading causes of death during the study period.During 2010-2022, preventable premature deaths from heart disease increased most in noncore (+9.5%) and micropolitan counties (+9.1%) and decreased most in large central metropolitan counties (-10.2%). Preventable premature deaths from cancer decreased in all county categories, with the largest decreases in large central metropolitan and large fringe metropolitan counties (-100.0%; benchmark achieved in bot","PeriodicalId":48549,"journal":{"name":"Mmwr Surveillance Summaries","volume":"73 2","pages":"1-11"},"PeriodicalIF":37.3,"publicationDate":"2024-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11065459/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140856572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surveillance of Waterborne Disease Outbreaks Associated with Drinking Water - United States, 2015-2020. 2015-2020 年美国与饮用水有关的水传播疾病暴发监测》(Surveillance of Waterborne Disease Outbreaks Associated with Drinking Water)。
IF 24.9 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-03-14 DOI: 10.15585/mmwr.ss7301a1
Jasen M Kunz, Hannah Lawinger, Shanna Miko, Megan Gerdes, Muhammad Thuneibat, Elizabeth Hannapel, Virginia A Roberts
<p><strong>Problem/condition: </strong>Public health agencies in U.S. states, territories, and freely associated states investigate and voluntarily report waterborne disease outbreaks to CDC through the National Outbreak Reporting System (NORS). This report summarizes NORS drinking water outbreak epidemiologic, laboratory, and environmental data, including data for both public and private drinking water systems. The report presents outbreak-contributing factors (i.e., practices and factors that lead to outbreaks) and, for the first time, categorizes outbreaks as biofilm pathogen or enteric illness associated.</p><p><strong>Period covered: </strong>2015-2020.</p><p><strong>Description of system: </strong>CDC launched NORS in 2009 as a web-based platform into which public health departments voluntarily enter outbreak information. Through NORS, CDC collects reports of enteric disease outbreaks caused by bacterial, viral, parasitic, chemical, toxin, and unknown agents as well as foodborne and waterborne outbreaks of nonenteric disease. Data provided by NORS users, when known, for drinking water outbreaks include 1) the number of cases, hospitalizations, and deaths; 2) the etiologic agent (confirmed or suspected); 3) the implicated type of water system (e.g., community or individual or private); 4) the setting of exposure (e.g., hospital or health care facility; hotel, motel, lodge, or inn; or private residence); and 5) relevant epidemiologic and environmental data needed to describe the outbreak and characterize contributing factors.</p><p><strong>Results: </strong>During 2015-2020, public health officials from 28 states voluntarily reported 214 outbreaks associated with drinking water and 454 contributing factor types. The reported etiologies included 187 (87%) biofilm associated, 24 (11%) enteric illness associated, two (1%) unknown, and one (<1%) chemical or toxin. A total of 172 (80%) outbreaks were linked to water from public water systems, 22 (10%) to unknown water systems, 17 (8%) to individual or private systems, and two (0.9%) to other systems; one (0.5%) system type was not reported. Drinking water-associated outbreaks resulted in at least 2,140 cases of illness, 563 hospitalizations (26% of cases), and 88 deaths (4% of cases). Individual or private water systems were implicated in 944 (43%) cases, 52 (9%) hospitalizations, and 14 (16%) deaths.Enteric illness-associated pathogens were implicated in 1,299 (61%) of all illnesses, and 10 (2%) hospitalizations. No deaths were reported. Among these illnesses, three pathogens (norovirus, Shigella, and Campylobacter) or multiple etiologies including these pathogens resulted in 1,225 (94%) cases. The drinking water source was identified most often (n = 34; 7%) as the contributing factor in enteric disease outbreaks. When water source (e.g., groundwater) was known (n = 14), wells were identified in 13 (93%) of enteric disease outbreaks.Most biofilm-related outbreak reports implicated Legionella (n =
问题/条件:美国各州、领地和自由联系州的公共卫生机构通过国家疫情报告系统 (NORS) 调查并自愿向疾病预防控制中心报告水传播疾病疫情。本报告总结了 NORS 饮用水疫情的流行病学、实验室和环境数据,包括公共和私营饮用水系统的数据。报告介绍了导致疫情暴发的因素(即导致疫情暴发的做法和因素),并首次将疫情暴发归类为生物膜病原体或肠道疾病相关因素:疾病预防控制中心于 2009 年启动了 NORS,这是一个基于网络的平台,公共卫生部门可自愿将疫情信息输入该平台。通过 NORS,疾控中心收集由细菌、病毒、寄生虫、化学、毒素和未知病原体引起的肠道疾病暴发报告,以及由食物和水传播引起的非肠道疾病暴发报告。NORS 用户提供的已知饮用水疫情数据包括:1)病例数、住院人数和死亡人数;2)病原体(确诊或疑似);3)涉及的供水系统类型(如社区或个人或私人供水系统);4)接触环境(如医院或医疗机构;酒店、汽车旅馆、旅馆或客栈;或私人住宅);5)描述疫情和确定诱因所需的相关流行病学和环境数据:2015-2020 年间,28 个州的公共卫生官员自愿报告了 214 起与饮用水有关的疫情和 454 种诱因类型。报告的病因包括:187 例(87%)与生物膜相关,24 例(11%)与肠道疾病相关,2 例(1%)未知,1 例(解释:生物膜和肠道疾病相关的病因范围较广:所观察到的生物膜和肠道饮用水病原体致病因素的范围说明了饮用水相关疾病预防的复杂性和水源到水龙头预防策略的必要性。随着时间的推移,与军团菌相关的疾病暴发数量不断增加,是报告的饮用水疾病暴发(包括住院和死亡)的主要原因。在本报告所述期间,主要与水井有关的肠道疾病暴发约占病例总数的一半。本报告加强了疾病预防控制中心对美国水传播疾病的发病率和医疗成本影响的估算,该估算显示,生物膜相关病原体、非结核性真菌和军团菌已成为水传播疾病和饮用水相关疾病导致住院和死亡的主要原因:公共卫生部门、监管机构和饮用水合作伙伴可以利用这些发现来识别新出现的水传播疾病威胁,指导疫情应对和预防计划,并支持饮用水监管工作。
{"title":"Surveillance of Waterborne Disease Outbreaks Associated with Drinking Water - United States, 2015-2020.","authors":"Jasen M Kunz, Hannah Lawinger, Shanna Miko, Megan Gerdes, Muhammad Thuneibat, Elizabeth Hannapel, Virginia A Roberts","doi":"10.15585/mmwr.ss7301a1","DOIUrl":"10.15585/mmwr.ss7301a1","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Problem/condition: &lt;/strong&gt;Public health agencies in U.S. states, territories, and freely associated states investigate and voluntarily report waterborne disease outbreaks to CDC through the National Outbreak Reporting System (NORS). This report summarizes NORS drinking water outbreak epidemiologic, laboratory, and environmental data, including data for both public and private drinking water systems. The report presents outbreak-contributing factors (i.e., practices and factors that lead to outbreaks) and, for the first time, categorizes outbreaks as biofilm pathogen or enteric illness associated.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Period covered: &lt;/strong&gt;2015-2020.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Description of system: &lt;/strong&gt;CDC launched NORS in 2009 as a web-based platform into which public health departments voluntarily enter outbreak information. Through NORS, CDC collects reports of enteric disease outbreaks caused by bacterial, viral, parasitic, chemical, toxin, and unknown agents as well as foodborne and waterborne outbreaks of nonenteric disease. Data provided by NORS users, when known, for drinking water outbreaks include 1) the number of cases, hospitalizations, and deaths; 2) the etiologic agent (confirmed or suspected); 3) the implicated type of water system (e.g., community or individual or private); 4) the setting of exposure (e.g., hospital or health care facility; hotel, motel, lodge, or inn; or private residence); and 5) relevant epidemiologic and environmental data needed to describe the outbreak and characterize contributing factors.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;During 2015-2020, public health officials from 28 states voluntarily reported 214 outbreaks associated with drinking water and 454 contributing factor types. The reported etiologies included 187 (87%) biofilm associated, 24 (11%) enteric illness associated, two (1%) unknown, and one (&lt;1%) chemical or toxin. A total of 172 (80%) outbreaks were linked to water from public water systems, 22 (10%) to unknown water systems, 17 (8%) to individual or private systems, and two (0.9%) to other systems; one (0.5%) system type was not reported. Drinking water-associated outbreaks resulted in at least 2,140 cases of illness, 563 hospitalizations (26% of cases), and 88 deaths (4% of cases). Individual or private water systems were implicated in 944 (43%) cases, 52 (9%) hospitalizations, and 14 (16%) deaths.Enteric illness-associated pathogens were implicated in 1,299 (61%) of all illnesses, and 10 (2%) hospitalizations. No deaths were reported. Among these illnesses, three pathogens (norovirus, Shigella, and Campylobacter) or multiple etiologies including these pathogens resulted in 1,225 (94%) cases. The drinking water source was identified most often (n = 34; 7%) as the contributing factor in enteric disease outbreaks. When water source (e.g., groundwater) was known (n = 14), wells were identified in 13 (93%) of enteric disease outbreaks.Most biofilm-related outbreak reports implicated Legionella (n =","PeriodicalId":48549,"journal":{"name":"Mmwr Surveillance Summaries","volume":"73 1","pages":"1-23"},"PeriodicalIF":24.9,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140111922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abortion Surveillance - United States, 2021. 堕胎监控-美国,2021年。
IF 24.9 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-11-24 DOI: 10.15585/mmwr.ss7209a1
Katherine Kortsmit, Antoinette T Nguyen, Michele G Mandel, Lisa M Hollier, Stephanie Ramer, Jessica Rodenhizer, Maura K Whiteman
<p><strong>Problem/condition: </strong>CDC conducts abortion surveillance to document the number and characteristics of women obtaining legal induced abortions and number of abortion-related deaths in the United States.</p><p><strong>Period covered: </strong>2021.</p><p><strong>Description of system: </strong>Each year, CDC requests abortion data from the central health agencies for the 50 states, the District of Columbia, and New York City. For 2021, a total of 48 reporting areas voluntarily provided aggregate abortion data to CDC. Of these, 47 reporting areas provided data each year during 2012-2021. Census and natality data were used to calculate abortion rates (number of abortions per 1,000 women aged 15-44 years) and ratios (number of abortions per 1,000 live births), respectively. Abortion-related deaths from 2020 were assessed as part of CDC's Pregnancy Mortality Surveillance System (PMSS).</p><p><strong>Results: </strong>A total of 625,978 abortions for 2021 were reported to CDC from 48 reporting areas. Among 47 reporting areas with data each year during 2012-2021, in 2021, a total of 622,108 abortions were reported, the abortion rate was 11.6 abortions per 1,000 women aged 15-44 years, and the abortion ratio was 204 abortions per 1,000 live births. From 2020 to 2021, the total number of abortions increased 5% (from 592,939 total abortions), the abortion rate increased 5% (from 11.1 abortions per 1,000 women aged 15-44 years), and the abortion ratio increased 4% (from 197 abortions per 1,000 live births). From 2012 to 2021, the total number of reported abortions decreased 8% (from 673,634), the abortion rate decreased 11% (from 13.1 abortions per 1,000 women aged 15-44 years), and the abortion ratio decreased 1% (from 207 abortions per 1,000 live births).In 2021, women in their 20s accounted for more than half of abortions (57.0%). Women aged 20-24 and 25-29 years accounted for the highest percentages of abortions (28.3% and 28.7%, respectively) and had the highest abortion rates (19.7 and 19.4 abortions per 1,000 women aged 20-24 and 25-29 years, respectively). By contrast, adolescents aged <15 years and women aged ≥40 years accounted for the lowest percentages of abortions (0.2% and 3.6%, respectively) and had the lowest abortion rates (0.4 and 2.5 abortions per 1,000 women aged <15 and ≥40 years, respectively). However, abortion ratios were highest among adolescents (aged ≤19 years) and lowest among women aged 30-39 years.From 2020 to 2021, abortion rates increased among women aged 20-39 years, decreased among adolescents aged 15-19 years, and did not change among adolescents aged <15 years and women aged ≥40 years. Abortion rates decreased from 2012 to 2021 among all age groups, except women aged 30-34 years for whom it increased. The decrease in the abortion rate from 2012 to 2021 was highest among adolescents compared with any other age group. From 2020 to 2021, abortion ratios increased for women aged 15-24 years, decreased among a
问题/状况:疾病预防控制中心进行堕胎监测,记录美国获得合法人工流产的妇女人数和特点以及与堕胎有关的死亡人数。涵盖期间:2021年。系统描述:每年,疾病预防控制中心要求50个州、哥伦比亚特区和纽约市的中央卫生机构提供堕胎数据。2021年,共有48个报告地区自愿向疾病预防控制中心提供堕胎汇总数据。其中,47个报告领域在2012-2021年期间每年提供数据。人口普查和出生数据分别用于计算堕胎率(每1,000名15-44岁妇女的堕胎次数)和比率(每1,000名活产的堕胎次数)。作为疾病预防控制中心妊娠死亡率监测系统(PMSS)的一部分,评估了2020年以来与堕胎相关的死亡。结果:48个报告地区2021年共向疾病预防控制中心报告625978例堕胎。在2012-2021年每年有数据的47个报告地区中,2021年共报告堕胎622108例,堕胎率为每千名15-44岁妇女11.6例堕胎,堕胎率为每千名活产204例堕胎。从2020年到2021年,堕胎总数增加了5%(从592,939例堕胎总数增加),堕胎率增加了5%(从每1,000名15-44岁妇女11.1例堕胎),堕胎率增加了4%(从每1,000名活产婴儿197例堕胎)。从2012年到2021年,报告的堕胎总数下降了8%(从673,634起),堕胎率下降了11%(从每1,000名15-44岁妇女的13.1起堕胎),堕胎率下降了1%(从每1,000名活产妇女的207起堕胎)。2021年,20多岁的女性占堕胎人数的一半以上(57.0%)。20-24岁和25-29岁妇女的堕胎比例最高(分别为28.3%和28.7%),堕胎率最高(每1000名20-24岁和25-29岁妇女的堕胎率分别为19.7和19.4)。相比之下,13周妊娠的青少年仍≤8.7%。2021年流产率最高的是妊娠≤9周的早期药物流产(53.0%),其次是妊娠≤13周的手术流产(37.6%)、妊娠>13周的手术流产(6.4%)和妊娠>9周的药物流产(3.0%);(解释:在2012-2021年连续报告数据的47个地区中,2012-2021年报告的堕胎总数、比率和比例总体下降;然而,从2020年到2021年,所有指标都出现了增长。公共卫生行动:堕胎监测可用于帮助评估旨在促进公平获得以患者为中心的优质避孕服务的计划,以减少美国的意外怀孕。
{"title":"Abortion Surveillance - United States, 2021.","authors":"Katherine Kortsmit, Antoinette T Nguyen, Michele G Mandel, Lisa M Hollier, Stephanie Ramer, Jessica Rodenhizer, Maura K Whiteman","doi":"10.15585/mmwr.ss7209a1","DOIUrl":"10.15585/mmwr.ss7209a1","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Problem/condition: &lt;/strong&gt;CDC conducts abortion surveillance to document the number and characteristics of women obtaining legal induced abortions and number of abortion-related deaths in the United States.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Period covered: &lt;/strong&gt;2021.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Description of system: &lt;/strong&gt;Each year, CDC requests abortion data from the central health agencies for the 50 states, the District of Columbia, and New York City. For 2021, a total of 48 reporting areas voluntarily provided aggregate abortion data to CDC. Of these, 47 reporting areas provided data each year during 2012-2021. Census and natality data were used to calculate abortion rates (number of abortions per 1,000 women aged 15-44 years) and ratios (number of abortions per 1,000 live births), respectively. Abortion-related deaths from 2020 were assessed as part of CDC's Pregnancy Mortality Surveillance System (PMSS).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 625,978 abortions for 2021 were reported to CDC from 48 reporting areas. Among 47 reporting areas with data each year during 2012-2021, in 2021, a total of 622,108 abortions were reported, the abortion rate was 11.6 abortions per 1,000 women aged 15-44 years, and the abortion ratio was 204 abortions per 1,000 live births. From 2020 to 2021, the total number of abortions increased 5% (from 592,939 total abortions), the abortion rate increased 5% (from 11.1 abortions per 1,000 women aged 15-44 years), and the abortion ratio increased 4% (from 197 abortions per 1,000 live births). From 2012 to 2021, the total number of reported abortions decreased 8% (from 673,634), the abortion rate decreased 11% (from 13.1 abortions per 1,000 women aged 15-44 years), and the abortion ratio decreased 1% (from 207 abortions per 1,000 live births).In 2021, women in their 20s accounted for more than half of abortions (57.0%). Women aged 20-24 and 25-29 years accounted for the highest percentages of abortions (28.3% and 28.7%, respectively) and had the highest abortion rates (19.7 and 19.4 abortions per 1,000 women aged 20-24 and 25-29 years, respectively). By contrast, adolescents aged &lt;15 years and women aged ≥40 years accounted for the lowest percentages of abortions (0.2% and 3.6%, respectively) and had the lowest abortion rates (0.4 and 2.5 abortions per 1,000 women aged &lt;15 and ≥40 years, respectively). However, abortion ratios were highest among adolescents (aged ≤19 years) and lowest among women aged 30-39 years.From 2020 to 2021, abortion rates increased among women aged 20-39 years, decreased among adolescents aged 15-19 years, and did not change among adolescents aged &lt;15 years and women aged ≥40 years. Abortion rates decreased from 2012 to 2021 among all age groups, except women aged 30-34 years for whom it increased. The decrease in the abortion rate from 2012 to 2021 was highest among adolescents compared with any other age group. From 2020 to 2021, abortion ratios increased for women aged 15-24 years, decreased among a","PeriodicalId":48549,"journal":{"name":"Mmwr Surveillance Summaries","volume":"72 9","pages":"1-29"},"PeriodicalIF":24.9,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684357/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138296198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Mmwr Surveillance Summaries
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1